Clinical Trial

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

Study acronym: NMR
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study was to learn about metabolomics profiles in vitreoretinal diseases by nuclear magnetic resonance (NMR)using vitreous fluid. The main question it aimed to answer was abnormal biomarkers for common retinal diseases such as idiopathic macular hole(IMH), diabetic retinopathy(DR) and retinal detachment(RD). Participants would not be subjected to any intervention and the investigators would only collect preoperative information and remaining vitreous samples. The investigators divided the participants into groups with appropriate disease names based on the disease diagnosis, such as IMH group, DR group, and RD group. The MH group was used as a control group, investigators compared other groups to see the metabolomic abnormalities.
Trial Details
NCT Number NCT06429969
Lead Sponsor Renmin Hospital of Wuhan University
Conditions Vitreoretinal Disease
Enrollment 450 participants
Start Date 2024-01-17
Primary Completion 2027-04-17 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-28